NO20006381D0 - Terapeutiske kombinasjoner av (selektive) östrogenreseptormodulatorer (SERM) og veksthormonsekresjonsmidler - Google Patents

Terapeutiske kombinasjoner av (selektive) östrogenreseptormodulatorer (SERM) og veksthormonsekresjonsmidler

Info

Publication number
NO20006381D0
NO20006381D0 NO20006381A NO20006381A NO20006381D0 NO 20006381 D0 NO20006381 D0 NO 20006381D0 NO 20006381 A NO20006381 A NO 20006381A NO 20006381 A NO20006381 A NO 20006381A NO 20006381 D0 NO20006381 D0 NO 20006381D0
Authority
NO
Norway
Prior art keywords
serm
selective
growth hormone
estrogen receptor
receptor modulators
Prior art date
Application number
NO20006381A
Other languages
English (en)
Other versions
NO20006381L (no
Inventor
Hua Zhu Ke
Mei Li
Lydia Codetta Pan
David Duane Thompson
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of NO20006381D0 publication Critical patent/NO20006381D0/no
Publication of NO20006381L publication Critical patent/NO20006381L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO20006381A 1998-06-16 2000-12-14 Terapeutiske kombinasjoner av (selektive) östrogenreseptormodulatorer (SERM) og veksthormonsekresjonsmidler NO20006381L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8942498P 1998-06-16 1998-06-16
PCT/IB1999/000796 WO1999065488A1 (en) 1998-06-16 1999-05-03 Therapeutic combinations of (selective) estrogen receptor modulators (serm) and growth hormone secretagogues (ghs) for treating musculoskeletal frailty

Publications (2)

Publication Number Publication Date
NO20006381D0 true NO20006381D0 (no) 2000-12-14
NO20006381L NO20006381L (no) 2000-12-14

Family

ID=22217565

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20006381A NO20006381L (no) 1998-06-16 2000-12-14 Terapeutiske kombinasjoner av (selektive) östrogenreseptormodulatorer (SERM) og veksthormonsekresjonsmidler

Country Status (29)

Country Link
EP (1) EP1085867A1 (no)
JP (1) JP2002518328A (no)
KR (1) KR20010052817A (no)
CN (1) CN1305378A (no)
AP (1) AP9901581A0 (no)
AR (1) AR018868A1 (no)
AU (1) AU3342099A (no)
BG (1) BG105128A (no)
BR (1) BR9911357A (no)
CA (1) CA2335112A1 (no)
CO (1) CO5070586A1 (no)
EA (1) EA200001189A1 (no)
GT (1) GT199900083A (no)
HR (1) HRP20000857A2 (no)
HU (1) HUP0102395A2 (no)
ID (1) ID26726A (no)
IL (1) IL139587A0 (no)
IS (1) IS5727A (no)
MA (1) MA26648A1 (no)
NO (1) NO20006381L (no)
OA (1) OA11569A (no)
PA (1) PA8472101A1 (no)
PE (1) PE20000633A1 (no)
PL (1) PL345064A1 (no)
SK (1) SK18902000A3 (no)
TN (1) TNSN99118A1 (no)
UY (1) UY25557A1 (no)
WO (1) WO1999065488A1 (no)
ZA (1) ZA993973B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1004306A3 (en) * 1998-08-06 2000-06-07 Pfizer Products Inc. Estrogen agonists/antagonists
CA2420535A1 (en) * 2000-08-30 2002-03-07 Mary Tanya Am Ende Sustained release formulations for growth hormone secretagogues
IL145106A0 (en) * 2000-08-30 2002-06-30 Pfizer Prod Inc Intermittent administration of a geowth hormone secretagogue
MXPA04005112A (es) * 2001-11-29 2005-04-29 Gtx Inc Prevencion y tratamiento de osteoporosis inducida por privacion de androgeno.
US7524866B2 (en) 2001-11-29 2009-04-28 Gtx, Inc. Prevention and treatment of androgen—deprivation induced osteoporosis
US7476653B2 (en) 2003-06-18 2009-01-13 Tranzyme Pharma, Inc. Macrocyclic modulators of the ghrelin receptor
CU23558A1 (es) 2006-02-28 2010-07-20 Ct Ingenieria Genetica Biotech Compuestos análogos a los secretagogos peptidicos de la hormona de crecimiento
ES2602789T3 (es) 2007-02-09 2017-02-22 Ocera Therapeutics, Inc. Productos intermedios conectores para la síntesis de moduladores macrocíclicos del receptor de la grelina

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA51676C2 (uk) * 1995-11-02 2002-12-16 Пфайзер Інк. (-)цис-6(s)-феніл-5(r)[4-(2-піролідин-1-ілетокси)феніл]-5,6,7,8-тетрагідронафталін-2-ол d-тартрат, спосіб його одержання, спосіб лікування захворювань, що піддаються лікуванню агоністами естрогену, та фармацевтична композиція
TW432073B (en) * 1995-12-28 2001-05-01 Pfizer Pyrazolopyridine compounds
HN1996000101A (es) * 1996-02-28 1997-06-26 Inc Pfizer Terapia combinada para la osteoporosis

Also Published As

Publication number Publication date
SK18902000A3 (sk) 2001-12-03
JP2002518328A (ja) 2002-06-25
BG105128A (en) 2001-11-30
PL345064A1 (en) 2001-11-19
IS5727A (is) 2000-11-24
AU3342099A (en) 2000-01-05
BR9911357A (pt) 2001-03-13
HRP20000857A2 (en) 2001-10-31
ZA993973B (en) 2000-12-15
WO1999065488A1 (en) 1999-12-23
CO5070586A1 (es) 2001-08-28
OA11569A (en) 2004-07-01
CA2335112A1 (en) 1999-12-23
UY25557A1 (es) 2001-01-31
PA8472101A1 (es) 2000-09-29
HUP0102395A2 (hu) 2001-11-28
KR20010052817A (ko) 2001-06-25
AR018868A1 (es) 2001-12-12
CN1305378A (zh) 2001-07-25
PE20000633A1 (es) 2000-07-26
ID26726A (id) 2001-02-01
GT199900083A (es) 2000-12-05
AP9901581A0 (en) 1999-06-30
TNSN99118A1 (fr) 2005-11-10
EP1085867A1 (en) 2001-03-28
NO20006381L (no) 2000-12-14
EA200001189A1 (ru) 2001-06-25
IL139587A0 (en) 2002-02-10
MA26648A1 (fr) 2004-12-20

Similar Documents

Publication Publication Date Title
NO20025143D0 (no) Modulatorer av reseptorer for paratyroid hormon og paratyriod hormonforbundet protein
NO20020912D0 (no) Bicykliske androgen- og progesteronreseptorer- modulatorforbindelser og fremgangsmåter
NO20024478D0 (no) Hormonerstatningsterapi ved anvendelse av kombinasjon av konjugerte östrogener og medroksyprogesteronacetat
NO981426D0 (no) Fremgangsmåte og anordning for primær-brönn-sementering
IL139915A0 (en) Improved methods and apparatus for multi-photon photo-activation of therapeutic agents
IS1886B (is) Stjórnuð losun stera úr sykruhúðum
EE200100053A (et) Biogeensete östrogeensulfamaatide kasutamine hormoonasendusraviks
AU4134101A (en) Hormone receptor functional entities and methods of their use
DE69838202D1 (de) Endpunktfühlung und Apparat
DK1089719T3 (da) Transdermalt terapeutisk system indeholdende hormoner og krystallisationsinhibitorer
NO991593D0 (no) Hormonpreparat bestÕende av en °strogenforbindelse og en progesteronforbindelse
DK0994706T3 (da) Præparater til oral indgivelse af taxaner og anvendelse deraf
NO20006313L (no) Terapeutiske kombinasjoner omfattende en selektiv östrogenreseptor modulator og paratyroidhormon
NO20006312D0 (no) Terapeutiske blandinger av selektive östrogenreseptor- modulatorer (SERM) og veksthormon sekretstimulerende middel (GHS) for behandling av muskuloskjelett skjörhet
EE05172B1 (et) Mesoprogestiinid (progesterooniretseptori modulaatorid) healoomuliste hormoons?ltuvate gnekoloogiliste haiguste raviks ja v„ltimiseks
NO20021947L (no) Bio-b¶rende matrikser, fremgangsmåte for fremstilling og anvendelse derav
CY2228B1 (en) Establishment of tonic ovarian estrogen secretion for extended therapeutic regimens
IS5727A (is) Meðferðarsamsetningar af (valvísum) estrógen viðtakabeinum (SERM) og vaxtarhormónaseytum (GHS) til að meðhöndla veikleika beinagrindarvöðva
NO20032969D0 (no) Fremgangsmåte for screening med hensyn på progesteronreseptorisoform-spesifikke ligander og med hensyn på vevs-selektiveprogesteronreseptorligander
LT97021A (en) Establishment of tonic ovarian estrogen secretion for extended therapeutic regimens
PL342666A1 (en) Method of testing therapeutic agents
AU1270099A (en) Human progesterone receptor complex p23-like protein
DK1047668T3 (da) Triazepinoner, fremgangsmåde til fremstilling deraf og terapeutisk anvendelse deraf
SI1265616T1 (sl) Hormonsko nadomestno zdravljenje z uporabo kombinacije konjugiranih estrogenov in medroksiprogesteron-acetata
AU4562100A (en) Method for passing a mixture of liquid through human and/or animal organs or extremities

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application